Patients entered into MRC AML trials are biologically representative of the totality of the disease in the UK.
Moorman
A V
AV
Roman
E
E
Cartwright
R A
RA
Morgan
G J
GJ
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic / Q000592:standards*; D003710:Demography; D005260:Female; D006801:Humans; D007951:Leukemia, Myeloid / Q000453:epidemiology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D006113:United Kingdom / Q000453:epidemiology